Literature DB >> 21222642

Role of protein conformational dynamics in the catalysis by 6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase.

Honggao Yan1, Xinhua Ji.   

Abstract

Enzymatic catalysis has conflicting structural requirements of the enzyme. In order for the enzyme to form a Michaelis complex, the enzyme must be in an open conformation so that the substrate can get into its active center. On the other hand, in order to maximize the stabilization of the transition state of the enzymatic reaction, the enzyme must be in a closed conformation to maximize its interactions with the transition state. The conflicting structural requirements can be resolved by a flexible active center that can sample both open and closed conformational states. For a bisubstrate enzyme, the Michaelis complex consists of two substrates in addition to the enzyme. The enzyme must remain flexible upon the binding of the first substrate so that the second substrate can get into the active center. The active center is fully assembled and stabilized only when both substrates bind to the enzyme. However, the side-chain positions of the catalytic residues in the Michaelis complex are still not optimally aligned for the stabilization of the transition state, which lasts only approximately 10(-13) s. The instantaneous and optimal alignment of catalytic groups for the transition state stabilization requires a dynamic enzyme, not an enzyme which undergoes a large scale of movements but an enzyme which permits at least a small scale of adjustment of catalytic group positions. This review will summarize the structure, catalytic mechanism, and dynamic properties of 6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase and examine the role of protein conformational dynamics in the catalysis of a bisubstrate enzymatic reaction.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21222642      PMCID: PMC3482336          DOI: 10.2174/092986611794654003

Source DB:  PubMed          Journal:  Protein Pept Lett        ISSN: 0929-8665            Impact factor:   1.890


  26 in total

1.  Protein-based virtual screening of chemical databases. 1. Evaluation of different docking/scoring combinations.

Authors:  C Bissantz; G Folkers; D Rognan
Journal:  J Med Chem       Date:  2000-12-14       Impact factor: 7.446

Review 2.  The folic acid biosynthesis pathway in bacteria: evaluation of potential for antibacterial drug discovery.

Authors:  Alun Bermingham; Jeremy P Derrick
Journal:  Bioessays       Date:  2002-07       Impact factor: 4.345

3.  Molecular motions and conformational changes of HPPK.

Authors:  O Keskin; X Ji; J Blaszcyk; D G Covell
Journal:  Proteins       Date:  2002-11-01

Review 4.  Where will new antibiotics come from?

Authors:  Christopher Walsh
Journal:  Nat Rev Microbiol       Date:  2003-10       Impact factor: 60.633

Review 5.  Thermodynamic and extrathermodynamic requirements of enzyme catalysis.

Authors:  Richard Wolfenden
Journal:  Biophys Chem       Date:  2003-09       Impact factor: 2.352

Review 6.  Inhibition of folate biosynthesis and function as a basis for chemotherapy.

Authors:  G H Hitchings; J J Burchall
Journal:  Adv Enzymol Relat Areas Mol Biol       Date:  1965

7.  Mechanism of the conformational transitions in 6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase as revealed by NMR spectroscopy.

Authors:  Guangyu Li; Krzysztof Felczak; Genbin Shi; Honggao Yan
Journal:  Biochemistry       Date:  2006-10-17       Impact factor: 3.162

8.  Loop conformation and dynamics of the Escherichia coli HPPK apo-enzyme and its binary complex with MgATP.

Authors:  Rong Yang; Matthew C Lee; Honggao Yan; Yong Duan
Journal:  Biophys J       Date:  2005-04-08       Impact factor: 4.033

9.  The three-dimensional structure of the bifunctional 6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase/dihydropteroate synthase of Saccharomyces cerevisiae.

Authors:  Michael C Lawrence; Peter Iliades; Ross T Fernley; Janette Berglez; Patricia A Pilling; Ian G Macreadie
Journal:  J Mol Biol       Date:  2005-05-06       Impact factor: 5.469

10.  Catalytic roles of arginine residues 82 and 92 of Escherichia coli 6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase: site-directed mutagenesis and biochemical studies.

Authors:  Yue Li; Yan Wu; Jaroslaw Blaszczyk; Xinhua Ji; Honggao Yan
Journal:  Biochemistry       Date:  2003-02-18       Impact factor: 3.162

View more
  6 in total

1.  Bisubstrate analogue inhibitors of 6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase: New design with improved properties.

Authors:  Genbin Shi; Gary Shaw; Yu-He Liang; Priadarsini Subburaman; Yue Li; Yan Wu; Honggao Yan; Xinhua Ji
Journal:  Bioorg Med Chem       Date:  2011-11-23       Impact factor: 3.641

2.  Bisubstrate analog inhibitors of 6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase: new lead exhibits a distinct binding mode.

Authors:  Genbin Shi; Gary Shaw; Yue Li; Yan Wu; Honggao Yan; Xinhua Ji
Journal:  Bioorg Med Chem       Date:  2012-06-06       Impact factor: 3.641

3.  New ways to derivatize at position 6 of 7,7-dimethyl-7,8-dihydropterin.

Authors:  Genbin Shi; Xinhua Ji
Journal:  Tetrahedron Lett       Date:  2011-11-16       Impact factor: 2.415

4.  Structural enzymology and inhibition of the bi-functional folate pathway enzyme HPPK-DHPS from the biowarfare agent Francisella tularensis.

Authors:  Gary X Shaw; Yue Li; Genbin Shi; Yan Wu; Scott Cherry; Danielle Needle; Di Zhang; Joseph E Tropea; David S Waugh; Honggao Yan; Xinhua Ji
Journal:  FEBS J       Date:  2014-07-23       Impact factor: 5.542

5.  Structural insights into E. coli porphobilinogen deaminase during synthesis and exit of 1-hydroxymethylbilane.

Authors:  Navneet Bung; Meenakshi Pradhan; Harini Srinivasan; Gopalakrishnan Bulusu
Journal:  PLoS Comput Biol       Date:  2014-03-06       Impact factor: 4.475

6.  Bisubstrate inhibitors of 6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase: Transition state analogs for high affinity binding.

Authors:  Genbin Shi; Gary X Shaw; Fengxia Zhu; Sergey G Tarasov; Xinhua Ji
Journal:  Bioorg Med Chem       Date:  2020-11-09       Impact factor: 3.641

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.